FIORDOLIVA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 806
EU - Europa 277
AS - Asia 90
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.209
Nazione #
US - Stati Uniti d'America 806
IT - Italia 78
UA - Ucraina 48
SE - Svezia 47
IE - Irlanda 41
CI - Costa d'Avorio 32
SG - Singapore 30
CN - Cina 27
DE - Germania 23
TR - Turchia 18
DK - Danimarca 13
FI - Finlandia 11
KR - Corea 9
GB - Regno Unito 7
IN - India 6
FR - Francia 5
MA - Marocco 3
BE - Belgio 2
EU - Europa 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 1.209
Città #
Chandler 131
Fairfield 85
Ashburn 65
Jacksonville 63
Des Moines 52
Boardman 39
Dublin 37
Wilmington 36
Woodbridge 36
New York 34
Seattle 33
Abidjan 32
Houston 24
Cambridge 18
Lawrence 16
Princeton 16
San Mateo 14
Turin 14
Redmond 11
San Diego 10
Ann Arbor 9
Centro 8
Singapore 8
Beijing 7
Los Angeles 6
Pune 6
Ancona 5
Helsinki 5
Washington 5
Shanghai 4
Castelraimondo 3
Kilburn 3
Tolentino 3
Brussels 2
Civitanova Marche 2
Dallas 2
Marche 2
Montegiorgio 2
Wuhan 2
Amsterdam 1
Bevagna 1
Chicago 1
Chiswick 1
Clifton 1
Falconara Marittima 1
Guangzhou 1
Hangzhou 1
Harrison 1
Hounslow 1
Jiaxing 1
London 1
Milan 1
Philadelphia 1
Phoenix 1
Qingdao 1
Saint Petersburg 1
San Severino Marche 1
Seoul 1
Stockholm 1
Wuxi 1
Totale 871
Nome #
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 111
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 92
Managing hyponatremia in lung cancer: latest evidence and clinical implications 84
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 84
Hyponatremia in cancer patients: Time for a new approach 83
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 83
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 81
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 78
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 77
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 74
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 72
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 72
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 67
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 66
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 62
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 62
Totale 1.248
Categoria #
all - tutte 6.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 10 0 9 0 12 2 11 22
2020/2021288 16 23 31 9 32 16 21 50 26 24 22 18
2021/2022136 10 20 5 2 15 13 3 10 10 17 10 21
2022/2023367 18 47 22 31 22 84 0 20 77 0 38 8
2023/2024187 23 4 12 11 26 59 4 13 0 6 1 28
2024/2025102 66 26 8 2 0 0 0 0 0 0 0 0
Totale 1.248